Mantle cell lymphoma: open trials in United Kingdom

10 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT06084936
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Trial Treatment · Phase 3 · Hoffmann-La Roche
NHS Greater Glasgow and Clyde, Glasgow · Lincolnshire County Hospital, Lincoln · University College London Hospital, London · Christie Hospital NHS Trust, Manchester · Oxford Churchill Hospital, Oxford · Derriford Hospital, Plymouth
Registry updated 2026-11-05
NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
Leeds Teaching Hospitals NHS Trust, Leeds · Oxford University Hospitals NHS Foundation Trust, Oxford
Registry updated 2026-11-04
NCT06742996
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Trial Treatment · Phase 3 · BeOne Medicines
Birmingham Heartlands Hospital, Birmingham · The Royal Bournemouth and Christchurch Hospitals Nhs Foundation, Bournemouth · Beatson West of Scotland Cancer Centre, Glasgow · Oxford University Hospitals Nhs Trust Churchill Hospital, Headington · University College Hospital, London · Clatterbridge Cancer Centre, Metropolitan Borough of Wirral · Derriford Hospital, Plymouth
Registry updated 2026-10-29
NCT06564038
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Derriford · London · Oxford · Southampton
Registry updated 2026-10-28
NCT06697184
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Trial Treatment · Phase 1/2 · BeOne Medicines
Queen Elizabeth Hospital, Birmingham · St Jamess University Hospital, Leeds
Registry updated 2026-10-26
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Edinburgh Cancer Centre, Edinburgh · St Jamess University Hospital, Leeds · Freeman Hospital, Newcastle upon Tyne · Genesiscare Cambridge, Newmarket · Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich · Nottingham University Hospitals NHS Trust, Nottingham · Derriford Hospital, Plymouth
Registry updated 2026-10-05
NCT06980116
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Trial Treatment · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
St James's University Hospital, Leeds · University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth
Registry updated 2026-08-13
NCT05131022
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Trial Treatment · Phase 1 · Nurix Therapeutics, Inc.
The Beatson WOS Cancer Center, Glasgow · St James Hospital, Leeds · Clatterbridge Cancer Center NHS Foundation Trust, Liverpool · Sarah Cannon Research Institute UK, London · St. Bartholomew's Hospital, Barts NHS Trust, London · The Christie NHS Foundation Trust, Manchester · Oxford University Hospitals NHS Foundation Trust, Oxford · University Hospitals Plymouth NHS Trust, Plymouth · University Hospital Southampton NHS Foundation Trust, Southampton · Royal Marsden NHS Foundation Trust, Sutton
Registry updated 2026-07-02
NCT06045910
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Trial Treatment · Phase 1/2 · Cancer Research UK
University Hospital Birmingham NHS Foundation Trust, Birmingham · Cambridge University Hospitals, Cambridge · St James's University Hospital, Leeds · University Hospital London Hospital, London · The Christie Hospital, Manchester · Manchester Royal Infirmary, Manchester · Royal Marsden Hospital, Sutton
Registry updated 2025-07-28
NCT05635162
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Trial Treatment · Phase 2 · University College, London
Royal Derby Hospital, Derby · Beatson West of Scotland Cancer Centre, Glasgow · Clatterbridge Cancer Centre, Liverpool · St. Bartholomew's Hospital, London · Guy's Hospital, London · University College London Hospital, London · Christie Hospital, Manchester · Norfolk and Norwich University Hospitl, Norwich · Nottingham City Hospital, Nottingham · Churchill Hospital, Oxford · Derriford Hospital, Plymouth · Southampton General Hospital, Southampton · Royal Cornwall Hospital, Truro
Registry updated 2025-04-16

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error